Comments

Perspective Therapeutics

CATXAMEX
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$13.12
-1.98-13.11%
At Close: -
15 minutes delayed
Perspective Therapeutics (CATX) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Perspective Therapeutics (AMEX:CATX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Perspective Therapeutics (CATX)?

A

There have been no specific sales or earnings guidance reported for Perspective Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch